Rxo (RXO) EBIT Margin (2021 - 2025)
Rxo's EBIT Margin history spans 5 years, with the latest figure at 2.86% for Q4 2025.
- For Q4 2025, EBIT Margin fell 142.0% year-over-year to 2.86%; the TTM value through Dec 2025 reached 1.38%, down 15.0%, while the annual FY2025 figure was 1.38%, 15.0% down from the prior year.
- EBIT Margin reached 2.86% in Q4 2025 per RXO's latest filing, down from 0.49% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 4.73% in Q2 2022 to a low of 2.86% in Q4 2025.
- Average EBIT Margin over 5 years is 0.69%, with a median of 0.55% recorded in 2023.
- Peak YoY movement for EBIT Margin: tumbled -423bps in 2022, then skyrocketed 152bps in 2023.
- A 5-year view of EBIT Margin shows it stood at 4.14% in 2021, then plummeted by -102bps to 0.09% in 2022, then surged by 1703bps to 1.43% in 2023, then crashed by -201bps to 1.44% in 2024, then plummeted by -99bps to 2.86% in 2025.
- Per Business Quant, the three most recent readings for RXO's EBIT Margin are 2.86% (Q4 2025), 0.49% (Q3 2025), and 2.09% (Q1 2025).